SeqLL to Present at the H.C. Wainwright 24th Annual Global Conference
BILLERICA, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- SeqLL, a technology company specializing in life sciences, announced that CEO Daniel Jones will present a corporate overview at the H.C.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
BILLERICA, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- SeqLL, a technology company specializing in life sciences, announced that CEO Daniel Jones will present a corporate overview at the H.C. Wainwright 24th Annual Global Conference from September 12-14, 2022. The presentation will be available on-demand starting at 7:00 am ET on September 12. Attendees can register to view the presentation and request 1x1 meetings. SeqLL aims to advance genomic medicine through its True Single Molecule Sequencing platform, developing innovative solutions for scientific research.
Details
News Market Reaction – SQL
The recorded move for SQL in the trading session of this news was +3.55%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BILLERICA, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services for collaborative partnerships, today announced that Daniel Jones, CEO of SeqLL will present a corporate overview and be available for virtual 1x1 meetings at the upcoming H.C. Wainwright 24th Annual Global Conference taking place from September 12-14, 2022.
The presentation will be available on demand beginning at 7:00 am ET on Monday, September 12th. To view the presentation or request a 1x1 meeting, click HERE to register and attend the event.
About SeqLL Inc.
SeqLL Inc. (“SeqLL”) is a technology company providing life sciences instrumentation and research services in collaborative partnerships aimed at the development of novel scientific assets and intellectual property across multiple “omics” fields. The Company leverages its expertise with its True Single Molecule Sequencing (“tSMS®”) platform to empower scientists and researchers with improved genetic tools to better understand the molecular mechanisms of disease that is essential to the continued development of new breakthroughs in genomic medicine, and that hopefully address the critical concerns involved with today’s precision medicine. In sum, our experienced team works with our collaborators to develop innovative solutions tailored to the needs of each specific project.
Contacts:
Ashley R. Robinson
LifeSci Advisors, LLC
Tel: +1 (617) 430-7577
Email: arr@lifesciadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.